You are here

Novo Nordisk

Novo Nordisk outlays $1.09bn to boost GLP-1RA production in Brazil

Yahoo Finance

Wed, 04/9/25 - 11:18 am

drug manufacturing

HHS leaves door open to future Medicare coverage of obesity drugs

BioSpace

Tue, 04/8/25 - 11:54 am

Trump drops Biden’s proposal for Medicare to cover obesity drugs like Wegovy and Zepbound

CNBC

Sun, 04/6/25 - 11:40 pm

Novo Holdings nearly doubles earnings as Wegovy swells coffers

Yahoo/Reuters

Wed, 04/2/25 - 11:43 am

ACC25: Ozempic shows its value in PAD

Pharmaphorum

Mon, 03/31/25 - 10:03 am

type 2 diabetes

Novo inks $1B biobucks Lexicon obesity deal after seeing preclinical prospect shine with semaglutide

Fierce Biotech

Fri, 03/28/25 - 11:24 am

Lexicon Pharmaceuticals

BofA cuts Novo Nordisk shares target on expected Q1 earnings miss

Yahoo Finance

Fri, 03/28/25 - 11:22 am

Novo Nordisk pens $2B deal for triple G agonist tied to 15% weight loss at 12 weeks

Fierce Biotech

Mon, 03/24/25 - 11:20 am

United Laboratories

triple G agonists

Novo Nordisk offers cheaper Wegovy for all cash-paying patients at retail pharmacy

Fierce Pharma

Mon, 03/24/25 - 11:05 am

NovoCare Pharmacy

Brazil's Hypera to launch an Ozempic generic in 2026, CEO says

MSN/Reuters

Mon, 03/24/25 - 11:02 am

Lilly, Novo expand DTC reach of obesity meds after compound win

Pharma Voice

Mon, 03/24/25 - 10:58 am

'Not a cost-cutting exercise': Novo Nordisk CSO explains rationale behind pharma's R&D shake-up

Fierce Biotech

Thu, 03/20/25 - 11:17 am

Eli Lilly beats Novo Nordisk to launch weight-loss drug Mounjaro in India, at $50 for 5 mg vial

MSN/Reuters

Thu, 03/20/25 - 10:18 am

How a Novo Nordisk Foundation-funded project sparked ultra-processed food fight

Yahoo/Reuters

Thu, 03/13/25 - 11:38 am

Novo Nordisk Foundation

Novo Nordisk's Ozempic successor disappointed Wall Street again

Yahoo Finance

Mon, 03/10/25 - 11:13 am

clinical trials

Novo Nordisk welcomes patients to the Ozempic Era

Medical Marketing and Media

Mon, 03/10/25 - 09:29 am

pharma marketing

DTC advertising

Novo Nordisk to explore how GLP-1 drugs can help patients with addiction

Pharma Live

Thu, 03/6/25 - 10:17 pm

'For Novo Nordisk, I do not worry a lot about tariffs:' CEO Lars Jørgensen

Yahoo Finance

Thu, 03/6/25 - 11:39 am

Lars Jørgensen

In FDA obesity drug battle with compounders, Texas court allows Novo Nordisk to weigh in

Fierce Pharma

Thu, 03/6/25 - 11:02 am

drug compounding

Novo counters compounders with direct access channel for Wegovy, price cut for self-paying patients

Fierce Pharma

Wed, 03/5/25 - 11:59 am

drug compounding

Pages